Overall rank by patents
#6,652
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Foamix Pharamaceuticals Ltd.
USPTO PatentsView assignee record - 50 granted patents across 8 technology areas, active 2015–2020. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
50
Total patents granted
8
CPC technology areas
31.2
Avg claims per patent
-86%
5-year filing velocity
The verdict
Foamix holds 50 US patents across 8 technology areas, rank #6,652 of 50,000 tracked assignees.
- #6,652
- of 50,000 US assignees by volume
- Top 40%
- by Innovation Score (38.6/100)
- 31.2
- avg claims per patent
- -86%
- filing velocity, last 5 yrs
Portfolio overview
Foamix Pharamaceuticals Ltd. has been granted 50 US utility patents between 2015 and 2020, placing Foamix Pharamaceuticals Ltd. at rank #6,652 across all assignees tracked by PlainPatent. This portfolio spans 8 distinct Cooperative Patent Classification (CPC) subclasses, averaging 31.2 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, Foamix Pharamaceuticals Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Foamix sits between Formosa Plastics Corporation (50 patents, rank #6,648) and Gyrfalcon Technology Inc. (50 patents, rank #6,656) - the closest US assignees by grant volume. The composite Innovation Score of 38.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 6 grants, compared with 44 in the 2015–2019 window, a -86% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Foamix Pharamaceuticals Ltd.'s 31.2 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 8 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Foamix Pharamaceuticals Ltd. against peers pursuing similar technology classes.
Who files at Foamix's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Formosa Plastics
FORMOSA PLASTICS CORPORATION
50 patents
- FundaciÓ Institut…
FUNDACIÓ INSTITUT DE CIENCIES FOTÒNIQUES
50 patents
- Ferroelectric Mem…
Ferroelectric Memory GmbH
50 patents
- Fiduciary Benchma…
Fiduciary Benchmarks Insights, LLC
50 patents
- GEMA Switzerland
GEMA SWITZERLAND GMBH
50 patents
- Guangzhou Institu…
GUANGZHOU INSTITUTE OF ENERGY CONVERSION, CHINESE ACADEMY OF SCIENCES
50 patents
- Gustav Klauke
GUSTAV KLAUKE GMBH
50 patents
- Gyrfalcon Technol…
GYRFALCON TECHNOLOGY INC.
50 patents
- Foamix Pharamaceu… ◀
Foamix Pharamaceuticals Ltd.
50 patents
What this shows Foamix holds 50 patents at rank #6,652, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Foamix
By rank, the assignees closest to #6,652 in granted patent volume.
- Formosa Plastics Corporation #6,648 · 50 patents
- Fundació Institut DE Ciencies Fotòniques #6,649 · 50 patents
- Ferroelectric Memory Gmbh #6,650 · 50 patents
- Fiduciary Benchmarks Insights, Llc #6,651 · 50 patents
- GEMA Switzerland Gmbh #6,653 · 50 patents
- Guangzhou Institute OF Energy Conversion, Chinese Academy OF Sciences #6,654 · 50 patents
- Gustav Klauke Gmbh #6,655 · 50 patents
- Gyrfalcon Technology Inc. #6,656 · 50 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Foamix's primary technology class.
- The Regents Of The University Of California 1,779 in class
- L'oreal 1,250 in class
- Novartis Ag 988 in class
- The Procter & Gamble Company 985 in class
- The Board Of Regents Of The University Of Texas System 950 in class
- The United States Of America, As Represented By The Secretary, Department Of Health And Human Services 813 in class
- The Trustees Of The University Of Pennsylvania 768 in class
- Merck Sharp & Dohme Llc 760 in class
Foamix's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
39 Top 40% higher than 60% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 9 | 18.0% |
| 2016 | 5 | 10.0% |
| 2017 | 12 | 24.0% |
| 2018 | 6 | 12.0% |
| 2019 | 12 | 24.0% |
| 2020 | 6 | 12.0% |
Which technologies does Foamix Pharamaceuticals Ltd. patent most?
Top 8 of 8 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Complex
Velocity Declining
Frequently Asked Questions
How many patents does Foamix Pharamaceuticals Ltd. hold?
Foamix Pharamaceuticals Ltd. holds 50 US granted patents filed between 2015 and 2020, spanning 8 technology areas.
What is Foamix Pharamaceuticals Ltd.'s Innovation Score?
Foamix Pharamaceuticals Ltd. has an Innovation Score of 38.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Foamix Pharamaceuticals Ltd. focus on?
Foamix Pharamaceuticals Ltd.'s top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 48 patents. The company has filed patents in 8 CPC subclasses total.
Is Foamix Pharamaceuticals Ltd.'s patent filing rate increasing or decreasing?
Foamix Pharamaceuticals Ltd.'s recent filing velocity is -86% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Foamix Pharamaceuticals Ltd.'s patents?
Foamix Pharamaceuticals Ltd.'s patents average 31.2 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the Foamix Pharamaceuticals Ltd. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Foamix's 50 grants land it in the top 40% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Foamix ranks #6,652 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.